According to IO Biotech's latest financial reports the company has $0.11 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.14 B | -32.59% |
2021-12-31 | $0.21 B | 6112.36% |
2020-12-31 | $3.4 M | -56.6% |
2019-12-31 | $7.84 M |